Review article: non‐alcoholic fatty liver disease and hepatitis C – risk factors and clinical implications
- 14 October 2005
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 22 (s2), 48-51
- https://doi.org/10.1111/j.1365-2036.2005.02596.x
Abstract
Hepatitis C and non-alcoholic fatty liver disease (NAFLD) are the two most common liver diseases in the Western hemisphere. It is therefore natural that these conditions often co-exist in the same individual. Hepatitis C, especially genotype 3, is often associated with hepatic steatosis. In subjects with genotype 3 infection, a sustained virologic response to treatment is associated with improvement in hepatic steatosis. The diagnosis of NAFLD in a subject with hepatitis C infection is based on the presence of hepatic steatosis. Most investigators require the presence of at least grade II steatosis to warrant a diagnosis of concomitant NAFLD because the significance of minimal steatosis is uncertain. The presence of steatohepatitis is surmised by the additional presence of Mallory bodies, cytologic ballooning and pericellular fibrosis. It is of paramount importance to exclude alcohol as a cause of these histologic findings in this population before a diagnosis of NAFLD is made. The presence of NAFLD in subjects with hepatitis C genotype 1 infection is most strongly associated with the presence of the metabolic syndrome and insulin resistance. The degree of hepatic steatosis correlates with the degree of hepatic fibrosis and the presence of concomitant steatosis is associated with more advanced fibrosis. The presence of cytologic ballooning confers an additional risk for increased fibrosis. Insulin resistance and hyperinsulinemia have been associated with increased collagen production by hepatic stellate cells. Subjects with hepatitis C and NAFLD are more likely to be virologic nonresponders following anti-HCV therapy. The value of treating insulin resistance and NAFLD prior to antiviral therapy remains to be experimentally verified.Keywords
This publication has 33 references indexed in Scilit:
- Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosisLiver Transplantation, 2001
- Steatosis and bile duct damage in chronic hepatitis C: distribution and relationships in a group of Northern Italian patientsLiver International, 1999
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994The New England Journal of Medicine, 1999
- Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severityGastroenterology, 1999
- Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosisHepatology, 1999
- Syndrome XDrugs, 1999
- Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotypeHepatology, 1997
- Hepatitis C virus does not cause nonalcoholic steatohepatitisDigestive Diseases and Sciences, 1992
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitisHepatology, 1981